Immutep (PRRUF, $0.23) was one of the top gainers for the month, rising +2 to $0.23 per share. A.I.dvisor analyzed 870 stocks in the Biotechnology Industry for the month ending August 16, 2024 and discovered that of them (3) exhibited an Uptrend while of them (6) exhibited a Downtrend.